1336 participants
A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-14
- Start Date:
- 2018-04-09
- Completion:
- 2029-02-28
Conditions
- Crohn's Disease
Interventions
- DRUG
No Results Yet